Company / Operating Income per Share
Roivant Sciences Operating Income per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$6.46
FY2025
5-year range
-$2.02 / $6.46
FY2021-FY2025
Trend
+619.5%
vs FY2024
Sector context
#12 of 201
Health Care
What the data says
Operating Income per Share changed +620% YoY in FY2025, a notable deviation from the 5-year average annual change of +192%.
Based on SEC 10-K filings.
6.46 in FY2025. Top quartile in the Health Care sector.
Improved from $5.92 to $6.46 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 201This company $6.46 Sector average -$3.23
▼
+299.8% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 619.5% year-over-year.
- Ranks #12 out of 201 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.46 | +619.5% |
| FY2024 | -$1.24 | -121.0% |
| FY2023 | $5.92 | +460.0% |
| FY2022 | -$1.64 | +18.6% |
| FY2021 | -$2.02 | -18.7% |
| FY2020 | -$1.70 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026